An alarming number of women are unaware of the tell-tale signs of a deadly cancer that kills thousands each year, new ...

One woman's story of literal strength illustrates how ovarian cancer symptoms can be missed—and the lighthearted recovery ...

Jacquie Beltrao issued a huge announcement five years after she was told she had stage four breast cancer. The Sky News ...

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

The O'Hern sisters helped each other fight breast cancer. Now they're walking in the 2025 Kentucky Oaks Survivors Parade at ...

In May, the FDA granted significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Rising temperatures are linked to increases in the prevalence and mortality of breast, ovarian, uterine, and cervical cancers ...

One of the strongest risk factors for breast cancer is inherited genetic mutations, especially in the BRCA1 and BRCA2 genes.

Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.